Skip to content

Venrock Adviser, LLC

Follow

13F filer, CIK 1615982, NEW YORK, NY

Venrock Adviser, LLC reported $2,058,215,412 across 34 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 71% of the portfolio.

Accepted , ingested 13F-HR 0001615982-26-000019

Period
2026-09-30
Reported value
$2.06B
Holdings
34
Top 10 weight
71%
New
7
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KRSAnew+4,549,585$146M
DMRAnew+3,603,595$76.7M
ADRXnew+1,625,793$32.4M
ERASadded+2,198,120$32.2M
SVRAadded+4,822,591$24.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
APGEexited-8,493,321-$1.13B
DMRAexited-3,603,595-$93.7M
SYREreduced-500,000-$44.5M
DNTHreduced-357,980-$31.5M
ELVNexited-526,331-$26.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001615982-26-000019, largest first. % of portfolio is the value over $2,058,215,412, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,285,620 shares; 2025Q1: 4,148,428 shares; 2025Q2: 4,148,428 shares; 2025Q3: 4,148,428 shares; 2025Q4: 4,148,428 shares; 2026Q1: 4,148,428 shares; 2026Q2: 4,148,428 shares; 2026Q3: 4,148,428 shares 4,148,428$346M16.79%0Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 16,216,216 shares; 2025Q1: 16,216,216 shares; 2025Q2: 17,857,083 shares; 2025Q3: 17,857,083 shares; 2025Q4: 17,857,083 shares; 2026Q1: 16,382,812 shares; 2026Q2: 17,891,812 shares; 2026Q3: 20,089,932 shares 20,089,932$295M14.31%+2,198,120Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,685,448 shares; 2025Q1: 2,685,448 shares; 2025Q2: 2,685,448 shares; 2025Q3: 2,685,448 shares; 2025Q4: 3,685,448 shares; 2026Q1: 3,685,448 shares; 2026Q2: 2,985,448 shares; 2026Q3: 2,485,448 shares 2,485,448$221M10.75%-500,000Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,549,585 shares 4,549,585$146M7.07%newTimeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 3,257,639 shares; 2025Q2: 8,884,263 shares; 2025Q3: 12,681,043 shares; 2025Q4: 13,740,375 shares; 2026Q1: 13,740,375 shares; 2026Q2: 14,745,943 shares; 2026Q3: 19,568,534 shares 19,568,534$101M4.91%+4,822,591Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,762,462 shares; 2025Q1: 12,762,462 shares; 2025Q2: 12,762,462 shares; 2025Q3: 13,161,462 shares; 2025Q4: 7,315,547 shares; 2026Q1: 10,346,926 shares; 2026Q2: 10,346,926 shares; 2026Q3: 10,346,926 shares 10,346,926$79.4M3.86%0Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,603,595 shares 3,603,595$76.7M3.73%newTimeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,744,373 shares; 2025Q1: 1,744,373 shares; 2025Q2: 1,000,000 shares; 2025Q3: 960,803 shares; 2025Q4: 1,000,000 shares; 2026Q1: 1,180,000 shares; 2026Q2: 1,180,000 shares; 2026Q3: 822,020 shares 822,020$72.4M3.52%-357,980Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,882,709 shares; 2025Q1: 3,882,709 shares; 2025Q2: 3,882,709 shares; 2025Q3: 3,882,709 shares; 2025Q4: 3,882,709 shares; 2026Q1: 3,882,709 shares; 2026Q2: 3,257,917 shares; 2026Q3: 3,257,917 shares 3,257,917$67.1M3.26%0Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 499,966 shares; 2025Q4: 1,943,766 shares; 2026Q1: 3,041,719 shares; 2026Q2: 3,041,719 shares; 2026Q3: 3,041,719 shares 3,041,719$58M2.82%0Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,684,411 shares; 2025Q1: 5,684,411 shares; 2025Q2: 4,755,411 shares; 2025Q3: 4,000,000 shares; 2025Q4: 2,000,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 1,642,166 shares; 2026Q3: 1,642,166 shares 1,642,166$52.6M2.55%0Timeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,212,731 shares; 2026Q2: 3,212,731 shares; 2026Q3: 3,212,731 shares 3,212,731$51.4M2.5%0Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,220,364 shares; 2025Q3: 3,220,364 shares; 2025Q4: 3,220,364 shares; 2026Q1: 3,220,364 shares; 2026Q2: 3,220,364 shares; 2026Q3: 3,220,364 shares 3,220,364$45.2M2.2%0Timeline
ACHVACHIEVE LIFE SCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,751,032 shares; 2026Q3: 5,502,064 shares 5,502,064$44.5M2.16%+2,751,032Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,230,769 shares; 2025Q4: 1,548,569 shares; 2026Q1: 1,602,034 shares; 2026Q2: 1,602,034 shares; 2026Q3: 1,545,616 shares 1,545,616$42M2.04%-56,418Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,394,527 shares; 2025Q1: 3,182,527 shares; 2025Q2: 6,596,885 shares; 2025Q3: 6,596,885 shares; 2025Q4: 5,676,230 shares; 2026Q1: 4,319,765 shares; 2026Q2: 4,319,765 shares; 2026Q3: 2,944,056 shares 2,944,056$39.7M1.93%-1,375,709Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,173,913 shares; 2025Q1: 2,173,913 shares; 2025Q2: 2,173,913 shares; 2025Q3: 2,173,913 shares; 2025Q4: 2,173,913 shares; 2026Q1: 2,173,913 shares; 2026Q2: 2,173,913 shares; 2026Q3: 2,173,913 shares 2,173,913$35M1.7%0Timeline
ADRXADARX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,625,793 shares 1,625,793$32.4M1.58%newTimeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,387,864 shares; 2025Q3: 1,387,864 shares; 2025Q4: 2,133,576 shares; 2026Q1: 2,133,576 shares; 2026Q2: 2,133,576 shares; 2026Q3: 2,133,734 shares 2,133,734$31.1M1.51%+158Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,843,380 shares; 2026Q2: 6,844,305 shares; 2026Q3: 7,445,050 shares 7,445,050$28.1M1.36%+600,745Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,023,166 shares; 2025Q1: 5,023,166 shares; 2025Q2: 4,631,216 shares; 2025Q3: 4,631,216 shares; 2025Q4: 5,345,115 shares; 2026Q1: 6,434,990 shares; 2026Q2: 6,434,990 shares; 2026Q3: 6,434,990 shares 6,434,990$26.8M1.3%0Timeline
XFORX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 330,525 shares; 2026Q2: 1,934,253 shares; 2026Q3: 7,644,072 shares 7,644,072$22.2M1.08%+5,709,819Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,379,965 shares; 2025Q1: 1,379,965 shares; 2025Q2: 1,379,965 shares; 2025Q3: 1,379,965 shares; 2025Q4: 1,379,965 shares; 2026Q1: 1,379,965 shares; 2026Q2: 1,379,965 shares; 2026Q3: 1,379,965 shares 1,379,965$21.2M1.03%0Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 632,931 shares; 2025Q2: 632,931 shares; 2025Q3: 632,931 shares; 2025Q4: 632,931 shares; 2026Q1: 632,931 shares; 2026Q2: 632,931 shares; 2026Q3: 632,931 shares 632,931$20.4M0.99%0Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 625,000 shares; 2026Q3: 625,000 shares 625,000$20.2M0.98%0Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,952,533 shares 1,952,533$15.1M0.73%newTimeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,957,186 shares; 2025Q1: 2,498,069 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 8,695,652 shares; 2026Q2: 8,695,652 shares; 2026Q3: 8,695,652 shares 8,695,652$14.9M0.72%0Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 5,106,337 shares 5,106,337$14.9M0.72%newTimeline
ARTVARTIVA BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,609,569 shares; 2025Q1: 1,609,569 shares; 2025Q2: 1,609,569 shares; 2025Q3: 1,609,569 shares; 2025Q4: 1,609,569 shares; 2026Q1: 1,609,569 shares; 2026Q2: 2,043,596 shares; 2026Q3: 2,043,596 shares 2,043,596$14.6M0.71%0Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 500,000 shares; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000$12.8M0.62%0Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,009,500 shares; 2026Q2: 1,009,500 shares; 2026Q3: 443,431 shares 443,431$4.39M0.21%-566,069Timeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$3.75M0.18%newTimeline
RACDRESEARCH ALLIANCE CORP IVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$3.6M0.17%newTimeline
INMINMED PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 32,685 shares; 2026Q3: 133,378 shares 133,378$181K0.01%+100,693Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
APGEAPOGEE THERAPEUTICS INC8,493,321$1.13Bshares
DMRADAMORA THERAPEUTICS INC3,603,595$93.7Mshares
ELVNENLIVEN THERAPEUTICS INC526,331$26.7Mshares
HELPCYBIN INC3,851,654$25.5Mshares
CTMXCYTOMX THERAPEUTICS INC.4,982,124$18.7Mshares
RACCRESEARCH ALLIANCE CORP III300,000$3.21Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001615982-26-000019 base2026-11-16